USC cardiology chief Saxon: 'People are using their phones for everything except their own health. We aim to change that.'

July 16, 2012 by Sony Salzman

MassDevice discusses medical devices for mobile phones and the future of networked patient care with Dr. Leslie Saxon, cardiology chief at the University of Southern California.

MassDevice.com news

As cardiology chief of the Keck School of Medicine at the University of Southern California, Dr. Leslie Saxon is spearheading a successful mobile health innovation center called the Center for Body Computing. Founded in 2010, the coalition works with engineers, device companies and thought leaders to develop mobile health software and apps.

Saxon's ultimate goal is to create a single platform that is the "epicenter of wireless health." The CBC has developed working relationships with device companies and innovators including Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX) and St. Jude Medical (NYSE:STJ). She also hosts an annual Body Computing Conference, which brings together cross-disciplinary leaders from medicine, design, gaming and pharmaceuticals.

Sign up to get our free newsletters delivered straight to your inbox

The goal of all this collaboration is a “Facebook for healthcare," where patients, doctors and manufacturers share data in a dynamic online space. With more than 5 billion people wielding mobile devices, Saxon believes it's time to re-think the way healthcare is consumed. MassDevice.com caught up with Saxon to discuss her vision for the future of mHealth.

MassDevice: How does the Center for Body Computing find fresh new ideas to develop?

Comments

Features

ResMed CEO Mick Farrell tells MassDevice.com about the history of ResMed, its sleep apnea devices and the future of treating chronic disease.

Dr. Robert Greenberg, founder & CEO of Second Sight Medical, chats with MassDevice.com in advance of his appearance at the Big 100 West to discuss the Argus II 'bionic eye.'

CEO Josh Kornberg tells MassDevice.com about cleaning house and how bad news for rival Stryker Corp. is helping to reinvigorate Skyline Medical.

In this MassDevice.com podcast, we speak with Glooko CEO Rick Altinger about the company's mobile diabetes management application for smartphones and how it has the potential to change the spectrum of care for one of the world's most common chronic diseases.

Renal denervation has won a lot of praise as a potential solution for patients with resistant hypertension, but the excessive celebration of early clinical trial results may be setting everyone up for a major letdown and a harsh backlash. This week cardiologists at the Transcatheter Cardiovascular Therapeutics conference, including those involved with Medtronic's and Boston Scientific's clinical trials, warned of the dangers of exaggeration.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp